{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T07:30:54Z","timestamp":1785396654307,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.medcli.2019.07.022","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T19:34:31Z","timestamp":1574192071000},"page":"61-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Whole body FDG-PET\/CT for the assessment of bone marrow infiltration in patients with newly diagnosed lymphoma"],"prefix":"10.1016","volume":"154","author":[{"given":"Wang","family":"Xiao-Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Xinyue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Lijun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2019.07.022_bib0225","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1399-6576.2008.01874.x","article-title":"Procedure-related pain among adult patients with hematologic malignancies","volume":"53","author":"Liden","year":"2009","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.medcli.2019.07.022_bib0230","first-page":"1030","article-title":"[PET\/CT image values in clinical staging of the patients with non-Hodgkin's lymphoma]","volume":"23","author":"Tang","year":"2015","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.medcli.2019.07.022_bib0235","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1002\/cncr.30672","article-title":"[(18) F]-FDG PET\/CT in the staging and management of indolent lymphoma: a prospective multicenter PET registry study","volume":"123","author":"Metser","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.medcli.2019.07.022_bib0240","first-page":"5727","article-title":"The significance of PET\/CT in the initial staging of Hodgkin lymphoma: experience outside clinical trials","volume":"37","author":"Angelopoulou","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.medcli.2019.07.022_bib0245","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.blre.2015.06.003","article-title":"Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma","volume":"29","author":"Adams","year":"2015","journal-title":"Blood Rev"},{"key":"10.1016\/j.medcli.2019.07.022_bib0250","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/MNM.0000000000000361","article-title":"Bone marrow uptake of indolent non-Hodgkin lymphoma on PET\/CT with histopathological correlation","volume":"36","author":"Lee","year":"2015","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.medcli.2019.07.022_bib0255","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/ajh.24241","article-title":"Is FDG-PET\/CT a sensitive and specific method for the detection of extranodal involvement in diffuse large B-cell lymphoma?","volume":"91","author":"Adams","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.medcli.2019.07.022_bib0260","doi-asserted-by":"crossref","first-page":"E182","DOI":"10.1002\/ajh.24061","article-title":"Increased bone marrow FDG uptake at PET\/CT is not a sufficient proof of bone marrow involvement in diffuse large B-cell lymphoma","volume":"90","author":"Adams","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.medcli.2019.07.022_bib0265","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/bjh.14217","article-title":"Overestimated value of FDG-PET based bone marrow evaluation in lymphoma","volume":"179","author":"Adams","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.medcli.2019.07.022_bib0270","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1177\/0284185114554824","article-title":"Direct comparison of visual and quantitative bone marrow FDG-PET\/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET\/CT live up to its promise?","volume":"56","author":"Adams","year":"2015","journal-title":"Acta Radiol"},{"key":"10.1016\/j.medcli.2019.07.022_bib0275","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/ajh.24044","article-title":"The role of bone marrow biopsy and FDG-PET\/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients","volume":"90","author":"Chen-Liang","year":"2015","journal-title":"Am J Hematol"},{"issue":"Suppl. 1","key":"10.1016\/j.medcli.2019.07.022_bib0280","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/hon.2214","article-title":"FDG-PET as a biomarker in lymphoma: from qualitative to quantitative analysis","volume":"33","author":"Meignan","year":"2015","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.medcli.2019.07.022_bib0285","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.crad.2015.06.087","article-title":"Whole-body diffusion-weighted MRI and (18)F-FDG PET\/CT can discriminate between different lymphoma subtypes","volume":"70","author":"Mosavi","year":"2015","journal-title":"Clin Radiol"},{"key":"10.1016\/j.medcli.2019.07.022_bib0290","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"Barrington","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.medcli.2019.07.022_bib0295","doi-asserted-by":"crossref","first-page":"iv19","DOI":"10.1093\/annonc\/mdy080","article-title":"Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Eichenauer","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.medcli.2019.07.022_bib0300","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bjh.14071","article-title":"(18) F-FDG PET\u2013CT and trephine biopsy assessment of bone marrow involvement in lymphoma","volume":"174","author":"Ujjani","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.medcli.2019.07.022_bib0305","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1007\/s00259-017-3647-y","article-title":"(18)F-FDG PET\u2013CT imaging versus bone marrow biopsy in pediatric Hodgkin's lymphoma: a quantitative assessment of marrow uptake and novel insights into clinical implications of marrow involvement","volume":"44","author":"Hassan","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.medcli.2019.07.022_bib0310","article-title":"Bone marrow trephine biopsy in Hodgkin's lymphoma. Comparison with PET\u2013CT scan in 65 patients","author":"Lakhwani","year":"2017","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2019.07.022_bib0315","first-page":"104","article-title":"The role of FDG-PET in Hodgkin lymphoma","volume":"21","author":"Subocz","year":"2017","journal-title":"Contemp Oncol (Pozn)"},{"issue":"Suppl. 5","key":"10.1016\/j.medcli.2019.07.022_bib0320","doi-asserted-by":"crossref","first-page":"v116","DOI":"10.1093\/annonc\/mdv304","article-title":"Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Tilly","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.medcli.2019.07.022_bib0325","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1177\/0284185117701305","article-title":"Use of FDG PET\/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy","volume":"58","author":"Teagle","year":"2017","journal-title":"Acta Radiol"},{"key":"10.1016\/j.medcli.2019.07.022_bib0330","doi-asserted-by":"crossref","first-page":"e0170299","DOI":"10.1371\/journal.pone.0170299","article-title":"PET\/CT scanner and bone marrow biopsy in detection of bone marrow involvement in diffuse large B-cell lymphoma","volume":"12","author":"El Karak","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.medcli.2019.07.022_bib0335","first-page":"469","article-title":"Bone marrow disease detection with FDG-PET\/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study","volume":"55","author":"Pelosi","year":"2011","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.medcli.2019.07.022_bib0340","doi-asserted-by":"crossref","first-page":"e2017029","DOI":"10.4084\/mjhid.2017.029","article-title":"FDG-PET scan: a new paradigm for follicular lymphoma management","volume":"9","author":"Gallamini","year":"2017","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.medcli.2019.07.022_bib0345","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/RLU.0000000000002320","article-title":"FDG PET for evaluation of bone marrow status in T-cell lymphoma","volume":"44","author":"Koh","year":"2019","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.medcli.2019.07.022_bib0350","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1097\/RLU.0000000000002516","article-title":"Diagnostic and prognostic value of using 18F-FDG PET\/CT for the evaluation of bone marrow involvement in peripheral T-cell lymphoma","volume":"44","author":"Abe","year":"2019","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.medcli.2019.07.022_bib0355","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1080\/10428194.2016.1253834","article-title":"Discussion of 18F-FDG PET\/CT imaging characteristics and diagnostic values of angioimmunoblastic T-cell lymphoma","volume":"58","author":"Shao","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.medcli.2019.07.022_bib0360","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3109\/0284186X.2015.1041652","article-title":"Lymphoma grading with FDG-PET\/CT readdressed: direct and timely histopathological correlation study","volume":"55","author":"Adams","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.medcli.2019.07.022_bib0365","first-page":"228","article-title":"18F-FDG-PET\/CT is effective in distinguishing myelofibrosis due to bone marrow infiltration of diffuse large B-cell lymphoma from triple-negative primary myelofibrosis","volume":"58","author":"Kumagai","year":"2017","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.medcli.2019.07.022_bib0370","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2214\/AJR.16.17133","article-title":"Renal masses detected on FDG PET\/CT in patients with lymphoma: imaging features differentiating primary renal cell carcinomas from renal lymphomatous involvement","volume":"208","author":"Nicolau","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.medcli.2019.07.022_bib0375","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4103\/0972-3919.198517","volume":"32","author":"Mehdikhani","year":"2017","journal-title":"Indian J Nucl Med"},{"key":"10.1016\/j.medcli.2019.07.022_bib0380","first-page":"277","article-title":"Synchronous Kikuchi-Fujimoto disease and gastric adenocarcinoma mimicking malignant lymphoma on (18)F-FDG PET\/CT","volume":"35","author":"Li","year":"2016","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1016\/j.medcli.2019.07.022_bib0385","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2967\/jnmt.116.176842","article-title":"18F-FDG PET\/CT imaging of primary gastric lymphoma","volume":"44","author":"Davis","year":"2016","journal-title":"J Nucl Med Technol"},{"key":"10.1016\/j.medcli.2019.07.022_bib0390","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/0972-3919.202250","article-title":"Peritoneal super scan on (18)F-FDG PET\u2013CT in a patient of Burkitt's lymphoma","volume":"32","author":"Roy","year":"2017","journal-title":"Indian J Nucl Med"},{"key":"10.1016\/j.medcli.2019.07.022_bib0395","first-page":"737","article-title":"Diagnostic usefulness of FDG-PET\/CT in advanced malignant lymphoma of the uterus: report of two cases","volume":"36","author":"Okuda","year":"2015","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.medcli.2019.07.022_bib0400","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MNM.0000000000000652","article-title":"The role of 18F-FDG PET\/CT in staging and restaging primary bone lymphoma","volume":"38","author":"Liu","year":"2017","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.medcli.2019.07.022_bib0405","first-page":"317","article-title":"FDG PET diagnosis of primary intracranial lymphoma: radiology\u2013pathology correlation","volume":"110","author":"Kenny","year":"2017","journal-title":"QJM"},{"key":"10.1016\/j.medcli.2019.07.022_bib0410","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1097\/RLU.0000000000001559","article-title":"Central nervous system involvement of intravascular large B-cell lymphoma on 18F-FDG PET\/CT","volume":"42","author":"Higashiyama","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.medcli.2019.07.022_bib0415","first-page":"298","article-title":"Role of (18)F-FDG PET\/CT in primary brain lymphoma","volume":"36","author":"de-Bonilla-Damia","year":"2017","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1016\/j.medcli.2019.07.022_bib0420","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5603\/NMR.2016.0029","article-title":"18F-FDG PET\/CT in the diagnosis of an extranodal relapse of diffuse large B-cell lymphoma (DLBCL): a clinical case with a literature review","volume":"19","author":"Chaushev","year":"2016","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"10.1016\/j.medcli.2019.07.022_bib0425","article-title":"18F-FDG PET\/CT in primary brain lymphoma","author":"Albano","year":"2017","journal-title":"J Neurooncol"},{"key":"10.1016\/j.medcli.2019.07.022_bib0430","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/RLU.0000000000001005","article-title":"Does delayed-time-point imaging improve 18F-FDG-PET in patients with MALT lymphoma? Observations in a series of 13 patients","volume":"41","author":"Mayerhoefer","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.medcli.2019.07.022_bib0435","doi-asserted-by":"crossref","first-page":"e3197","DOI":"10.1097\/MD.0000000000003197","article-title":"CT, MRI, and 18F-FDG PET\/CT findings in untreated pulmonary and hepatic B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) over a five-year period: a case report","volume":"95","author":"Dong","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.medcli.2019.07.022_bib0440","doi-asserted-by":"crossref","first-page":"A52","DOI":"10.1016\/j.ejrad.2017.01.023","article-title":"(18)F-FDG-PET\/MRI in lymphoma patients","volume":"94","author":"Ferdova","year":"2017","journal-title":"Eur J Radiol"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775319306311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775319306311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:49:52Z","timestamp":1758419392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775319306311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0025775319306311"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2019.07.022","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whole body FDG-PET\/CT for the assessment of bone marrow infiltration in patients with newly diagnosed lymphoma","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2019.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}